Peripheral Neuropathy Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Women who have been diagnosed with a specific type of breast cancer called invasive ductal carcinoma, at stages I, II, or III.
• Women between the ages of 30 and 65.
• Women who are 3 to 6 months past their breast cancer diagnosis.
• Women who have finished chemotherapy and are in a stable medical condition.
• Women who are experiencing nerve-related side effects from chemotherapy (such as tingling, numbness, or weakness), as measured by a standard questionnaire called the FACT/GOG-Ntx.
• Women whose balance has been affected, scoring 25 or below out of 40 on a standardised balance assessment called the Fullerton Advanced Balance scale.
• Women who undergo a series of physical and neurological tests, including checks of reflexes, sensation, sense of body position, and leg strength (confirm with trial site for full testing details).

Who may not be able to join:

• Women who have been diagnosed with any additional type of cancer beyond breast cancer.
• Women who have chronic medical conditions such as poorly controlled diabetes.
• Women who have significant neurological conditions (such as multiple sclerosis) or serious heart or lung disease (such as a heart attack within the past 3 months) that could affect physical performance.
• Women who have unstable bone metastasis (cancer that has spread to the bones and is not currently stable).

Important: Always verify eligibility with the trial site directly before applying.